Market Access Views & Analysis

Views & Analysis

Vertex Pharma’s vision for reimbursement innovation

As regional vice president for Northern Europe & Australia, Simon Lem led the digital launch of Vertex Pharma’s novel cystic fibrosis drug Kaftrio.

R&D

Enabling innovation by connecting an ecosystem of partners

COVID-19 has been a shock to the system for every industry, not least pharma, but the sector is already looking at new ways to build resilience for the future.

Views & Analysis

NICE talking to you: Trends in early HTA engagement

With exclusive data from Freedom of Information (FOI) requests sent to the National Institute for Health and are Excellence (NICE), Leela Barham takes a look at the trend in early engagemen

Views & Analysis

Pharma’s response to COVID: GSK

A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus on addressing the collateral damages and shaping the future.

Views & Analysis

Why intelligent automation is the future for regulation

Why intelligent automation is the future for regulatory

There are a host of new, previously unimaginable tools and techniques – from analytics to robotic process automation (RPA) and artificial intelligence (AI) – available to help speed up proc

Views & Analysis